FDA Approves Celltrion’s Zymfentra to Treat Ulcerative Colitis and Crohn’s Disease
The U.S. Food and Drug Administration (FDA) has approved Celltrion’s Zymfentra, a subcutaneous injection formulation of its infliximab Remsina, for maintenance therapy in adults with moderately to severely active ulcerative colitis and Crohn’s disease following treatment with an infliximab administered intravenously.
FDA Approves Wezlana, First Interchangeable Biosimilar to Stelara
The U.S. Food and Drug Administration (FDA) has approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy; active psoriatic arthritis; moderately to severely active Crohn’s disease; and moderately to severely active ulcerative colitis.
The Proven Success of Immune Globulin Therapy to Treat Chronic Inflammatory Demyelinating Polyneuropathy
Numerous studies show the efficacy of both IVIG and SCIG for treating CIDP, making these the best treatment options for this rare neurological condition.
Platelet-Rich Plasma Therapy: The Future of Healing?
The effectiveness of this controversial therapy in treating musculoskeletal disorders and other arthritic conditions is uncertain due to mixed results. Nevertheless, the PRP industry is booming.
Coming Soon: Dried Plasma for Hemorrhagic Trauma in the Prehospital Setting
It is now well-established that prehospital transfusion of plasma, with its balanced mix of coagulation proteins, counters the hemodilution and progressive derangement of hemostatic mechanisms caused by crystalloid-based resuscitation, improving the changes of survival in severely bleed trauma victims.
The Future of Orphan Drugs: Advancements, Challenges and Hope
In the realm of healthcare and pharmaceuticals, orphan drugs have emerged as a beacon of hope for individuals suffering from rare diseases. With new technology and AI-driven analytics as drivers, these once-niche therapies are rapidly taking center stage.
Personalized Healthcare
Precise, personal treatment is the way of the future. Here’s how experts are using genetic sequencing to forge a revolutionary new way of practicing medicine.
New mRNA-Based Therapy Effective in Treating Melanoma in Mouse Models
Investigators at the Icahn School of Medicine at Mount Sinai have designed an RNA-based strategy to activate dendritic cells, which play a key role in immune response, that eradicated tumors and prevented their recurrence in mouse models of melanoma.
Combination of IVIG and Corticosteroids Superior to Respective Monotherapies for Treatment of Relapsed ITP in Adults
The combination of intravenous immune globulin (IVIG) and corticosteroids is a more efficient and rapid treatment for relapsed immune thrombocytopenic purpura (ITP) in adults compared with the use of either therapy alone.
Early Albumin Administration May Reduce Mortality in Septic Shock and ARDS: Retrospective MIMIC III Database Study
A study has found that early albumin administration in septic shock patients with ARDS was independently associated with a reduction in 28-day mortality.
